Dose Ranging Study With LT, Monotherapy, PPAR

Completed · Phase 2/Phase 3

Conditions studied: Diabetes Mellitus II

In brief

A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects with Type 2 Diabetes

Key facts

Study ID

NCT00240383

Run by

Bristol-Myers Squibb

People needed

1260

Starts

2002-05-01

Expected to finish

2006-06-01

Last updated by the study team

2010-09-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1. HbA1c > 7.0% and ≤ 10.0% obtained at the Screening visit.
• 2. Men and women, 18-70 years of age Established Type 2 diabetes

You may not qualify if…

• 1. Symptomatic Type 2 diabetes defined as marked polyuria and polydipsia with greater than 10% weight loss during the last three months.
• 2. Administration of antihyperglycemic agents (other than thiazolidinediones) for more than three consecutive or a total of seven non-consecutive days during the four weeks prior to screening.
• 3. Administration of thiazolidinediones for more than three consecutive or a total of seven non-consecutive days during the six weeks prior to screening.

Where it is running

• Local Institution — Birmingham, Alabama, United States
• Local Institution — Huntsville, Alabama, United States
• Local Institution — Hot Springs, Arizona, United States
• Local Institution — Mesa, Arizona, United States
• Local Institution — Phoenix, Arizona, United States
• Local Institution — Tempe, Arizona, United States
• Local Institution — Tucson, Arizona, United States
• Local Institution — Fayette, Arkansas, United States
• Local Institution — Little Rock, Arkansas, United States
• Local Institution — Bakersfield, California, United States
• Local Institution — Concord, California, United States
• Local Institution — Encinitas, California, United States
• Local Institution — Fair Oaks, California, United States
• Local Institution — Fountain Valley, California, United States
• Local Institution — Fresno, California, United States
• Local Institution — La Jolla, California, United States
• Local Institution — Los Gatos, California, United States
• Local Institution — Orange, California, United States
• Local Institution — Raleigh, California, United States
• Local Institution — Riverside, California, United States
• Local Institution — Rolling Hills Estate, California, United States
• Local Institution — Roseville, California, United States
• Local Institution — Sacramento, California, United States
• Local Institution — San Diego, California, United States
• Local Institution — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.